|
271 |
Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population
Enthalten in Applied health economics and health policy Bd. 9, 6.8.2012, Nr. 6, date:11.2011: 377-387
|
|
|
|
272 |
Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population
Enthalten in Applied health economics and health policy Bd. 9, 6.8.2012, Nr. 5, date:9.2011: 293-303
|
|
|
|
273 |
Excessive Daytime Sleepiness in Patients with Parkinson’s Disease
Enthalten in CNS drugs Bd. 25, 1.3.2011, Nr. 3, date:3.2011: 203-212
|
|
|
|
274 |
Exclusion of Older People from Clinical Trials
Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 8, date:8.2011: 667-677
|
|
|
|
275 |
Experiences with Adverse Drug Reaction Reporting by Patients
Enthalten in Drug safety Bd. 35, 20.11.2012, Nr. 1, date:1.2012: 45-60
|
|
|
|
276 |
Explorative Evaluation of the Impact of Premenstrual Disorder on Daily Functioning and Quality of Life
Enthalten in The Patient Bd. 3, 24.8.2012, Nr. 2, date:6.2010: 125-132
|
|
|
|
277 |
Extended Cycles with the Combined Oral Contraceptive Chlormadinone Acetate 2 mg/Ethinylestradiol 0.03 mg
Enthalten in Clinical drug investigation Bd. 31, 29.8.2012, Nr. 4, date:4.2011: 269-277
|
|
|
|
278 |
Fever Following Immunization with Influenza A (H1N1) Vaccine in Children
Enthalten in Drug safety Bd. 33, 20.11.2012, Nr. 12, date:12.2010: 1109-1115
|
|
|
|
279 |
Fidaxomicin
Enthalten in Drugs in R & D Bd. 10, 27.11.2012, Nr. 1, date:5.2010: 37-45
|
|
|
|
280 |
Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms
Enthalten in PharmacoEconomics Bd. 28, 29.9.2012, Nr. 8, date:8.2010: 615-628
|
|
Administration
